JP2024510927A5 - - Google Patents
Info
- Publication number
- JP2024510927A5 JP2024510927A5 JP2023553029A JP2023553029A JP2024510927A5 JP 2024510927 A5 JP2024510927 A5 JP 2024510927A5 JP 2023553029 A JP2023553029 A JP 2023553029A JP 2023553029 A JP2023553029 A JP 2023553029A JP 2024510927 A5 JP2024510927 A5 JP 2024510927A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- exist
- substituted
- pabc
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163156156P | 2021-03-03 | 2021-03-03 | |
| US63/156,156 | 2021-03-03 | ||
| US202163186581P | 2021-05-10 | 2021-05-10 | |
| US63/186,581 | 2021-05-10 | ||
| US202163214540P | 2021-06-24 | 2021-06-24 | |
| US63/214,540 | 2021-06-24 | ||
| US202163237450P | 2021-08-26 | 2021-08-26 | |
| US63/237,450 | 2021-08-26 | ||
| PCT/US2022/018534 WO2022187370A1 (en) | 2021-03-03 | 2022-03-02 | Branched linkers for antibody-drug conjugates and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024510927A JP2024510927A (ja) | 2024-03-12 |
| JP2024510927A5 true JP2024510927A5 (cg-RX-API-DMAC10.html) | 2025-03-06 |
Family
ID=83155529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023553029A Pending JP2024510927A (ja) | 2021-03-03 | 2022-03-02 | 抗体-薬物コンジュゲートのための分岐リンカー及びその使用方法 |
Country Status (9)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4739347A1 (en) * | 2023-07-07 | 2026-05-13 | Solve Therapeutics, Inc. | Conjugates of drug units and targeting units and precursor compounds thereof |
| EP4791439A1 (en) * | 2023-10-13 | 2026-08-19 | Sutro Biopharma, Inc. | Dual payload antibody drug conjugates |
| CN122374045A (zh) * | 2023-10-16 | 2026-07-10 | 蜂鸟生物科技私人有限公司 | Her2结合分子 |
| WO2025083071A2 (en) * | 2023-10-16 | 2025-04-24 | Hummingbird Bioscience Pte. Ltd. | Antibody-drug conjugates |
| WO2026080692A1 (en) * | 2024-10-09 | 2026-04-16 | Sutro Biopharma, Inc. | Branched beta-glucuronide linker-payloads, protein conjugates thereof, and methods thereof |
| WO2026150353A2 (en) | 2025-01-11 | 2026-07-16 | Biohaven Therapeutics Ltd. | Antibody-drug conjugates for delivering cytotoxic agents |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9310374B2 (en) * | 2012-11-16 | 2016-04-12 | Redwood Bioscience, Inc. | Hydrazinyl-indole compounds and methods for producing a conjugate |
| WO2017083306A1 (en) * | 2015-11-09 | 2017-05-18 | R.P. Scherer Technologies, Llc | Anti-cd22 antibody-maytansine conjugates and methods of use thereof |
| HUE067016T2 (hu) * | 2015-11-25 | 2024-09-28 | Ligachem Biosciences Inc | Önfeláldozó csoportokat tartalmazó konjugátumok és ezekkel kapcsolos eljárások |
| EP3700577A1 (en) * | 2017-10-23 | 2020-09-02 | Mablink Bioscience | Ligand-drug-conjugate comprising a single molecular weight polysarcosine |
| WO2019113248A1 (en) * | 2017-12-07 | 2019-06-13 | The Regents Of The University Of California | Anti-upar antibody-drug conjugates and methods of use thereof |
| MX2020006010A (es) * | 2017-12-11 | 2020-10-16 | Triphase Res And Development Iii Corp | Conjugados de anticuerpo anti-cd22-maitansina, combinaciones y metodos de uso de los mismos. |
| WO2020154437A1 (en) * | 2019-01-23 | 2020-07-30 | R.P. Scherer Technologies, Llc | Glycoside-containing peptide linkers for antibody-drug conjugates |
| JP7546755B2 (ja) * | 2020-10-19 | 2024-09-06 | ジアンス・コンテンポラリー・アンプレックス・テクノロジー・リミテッド | 電池、電力利用装置及び電池の調製方法、設備 |
-
2022
- 2022-03-02 KR KR1020237030693A patent/KR20230165207A/ko active Pending
- 2022-03-02 AU AU2022230398A patent/AU2022230398A1/en active Pending
- 2022-03-02 BR BR112023017670A patent/BR112023017670A2/pt unknown
- 2022-03-02 EP EP22763981.2A patent/EP4301415A4/en active Pending
- 2022-03-02 US US18/276,432 patent/US20240148883A1/en active Pending
- 2022-03-02 JP JP2023553029A patent/JP2024510927A/ja active Pending
- 2022-03-02 MX MX2023010099A patent/MX2023010099A/es unknown
- 2022-03-02 WO PCT/US2022/018534 patent/WO2022187370A1/en not_active Ceased
- 2022-03-02 CA CA3210473A patent/CA3210473A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022518743A5 (cg-RX-API-DMAC10.html) | ||
| JP2024529466A5 (cg-RX-API-DMAC10.html) | ||
| RU2628311C2 (ru) | Молекула одноцепочечной нуклеиновой кислоты для контроля экспрессии генов | |
| CN101641372B (zh) | 模板固定的肽模拟物 | |
| JP2021502120A5 (cg-RX-API-DMAC10.html) | ||
| JPH08501071A (ja) | 1,5−アンヒドロヘキシトールヌクレオシド類似体および該類似体の医薬としての使用 | |
| JP2022543231A5 (cg-RX-API-DMAC10.html) | ||
| JP2020143066A5 (cg-RX-API-DMAC10.html) | ||
| BG61485B1 (bg) | N горе 4-оксикарбонил заместени 5'-деокси-5-флуороцитидини | |
| KR950704261A (ko) | 부신피질자극호르몬-방출 인자(crf) 길항물질 활성을 갖는 피라졸 및 피라졸로피리미딘(pyrazoles and pyrazolpyrimidnes having crf antagonist activity) | |
| JP2019501214A5 (cg-RX-API-DMAC10.html) | ||
| KR20140024833A (ko) | 신규한 시티딘계 대사길항제의 고분자 유도체 | |
| JP2020525502A5 (cg-RX-API-DMAC10.html) | ||
| WO2009092295A1 (zh) | 一组格尔德霉素衍生物及其制备方法 | |
| CN114805212B (zh) | 用于递送治疗或预防剂的脂质和脂质组合物 | |
| CN112574272A (zh) | 一种灵芝酸a衍生物的制备及其应用 | |
| WO2024005460A1 (ko) | 자가-희생기를 포함하는 화합물 및 이를 포함하는 리간드-약물 접합체 | |
| CA2602755A1 (en) | Antibacterial amide-macrocycles v | |
| AU2007345099B2 (en) | The tetracyclic anthraquinones possessing anti-cancer effect | |
| JP2023551203A5 (cg-RX-API-DMAC10.html) | ||
| CN102659843B (zh) | D,l-鸟嘌呤核苷类似物单磷酸酯及其制备方法和应用 | |
| US20120308646A1 (en) | Tetracyclic anthraquinones possessing anti-cancer properties | |
| Arosio et al. | Click chemistry to functionalise peptidomimetics | |
| Komatani et al. | Solid-phase total synthesis of sandramycin and its analogues | |
| Zhang et al. | Synthesis and biological evaluation of novel quaternary ammonium antibody drug conjugates based on camptothecin derivatives |